These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 236061)

  • 21. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
    J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE; Reighlin S
    N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
    [No Abstract]   [Full Text] [Related]  

  • 23. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of lergotrile on galactorrhea and gonadotropin secretion.
    Cleary RE; Crabtree R; Lemberger L
    J Clin Endocrinol Metab; 1975 May; 40(5):830-3. PubMed ID: 165221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine-induced pregnancies in the amenorrhoea-galactorrhoea syndrome.
    Mustaffa BE; Khalid BA; Satgunasingam N; Adeeb N; Tan PL; Chandran S
    Med J Malaysia; 1983 Sep; 38(3):237-43. PubMed ID: 6672568
    [No Abstract]   [Full Text] [Related]  

  • 26. Tranquillizer-induced galactorrhea.
    Hussain MZ; Harinath M; Murphy J
    Can Med Assoc J; 1972 May; 106(10):1107-8. PubMed ID: 5064121
    [No Abstract]   [Full Text] [Related]  

  • 27. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
    Schellekens LA; Roland R; Lequin RM
    Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of bromocriptine on neuroleptic-induced amenorrhea, galactorrhea and impotence.
    Matsuoka I; Nakai T; Miyake M; Hirai M; Ikawa G
    Jpn J Psychiatry Neurol; 1986 Dec; 40(4):639-46. PubMed ID: 2885437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility.
    Varga L; Wenner R; Del Pozo E
    Am J Obstet Gynecol; 1973 Sep; 117(1):75-9. PubMed ID: 4722381
    [No Abstract]   [Full Text] [Related]  

  • 30. [The values of prelactin, FSH and LH in the course of galactorrhoea (author's transl)].
    Stehlíková J; Talas M; Fingerová H
    Cesk Gynekol; 1975 Sep; 40(8):603-5. PubMed ID: 1238174
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of lactation with 2 Br-alpha-ergocryptine].
    Jaszmann L; Szabó E; Szontágh F
    Orv Hetil; 1974 Sep; 115(35):2053-4. PubMed ID: 4603634
    [No Abstract]   [Full Text] [Related]  

  • 32. Restoration of ovarian function in patients with the amenorrhea-galactorrhea syndrome after long-term therapy with L-dopa.
    Zárate A; Canales ES; Jacobs LS; Maneiro PJ; Soria J; Daughaday WH
    Fertil Steril; 1973 May; 24(5):340-4. PubMed ID: 4735421
    [No Abstract]   [Full Text] [Related]  

  • 33. Galactorrhea-amenorrhea due to primary hypothyroidism.
    Boroditsky RS; Faiman C
    Am J Obstet Gynecol; 1973 Jul; 116(5):661-5. PubMed ID: 4713129
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of acute administration of L-dopa on serum concentrations of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in patients with the amenorrhea-galactorrhea syndrome.
    Zárate A; Canales ES; Soria J; Maneiro PJ; MacGregor C
    Neuroendocrinology; 1973; 12(6):362-5. PubMed ID: 4796782
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine.
    Thorner MO; McNeilly AS; Hagan C; Besser GM
    Br Med J; 1974 May; 2(5916):419-22. PubMed ID: 4600593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyridoxine treatment of galactorrhoea-amenorrhoea syndromes.
    Lehtovirta P; Ranta T; Seppälä M
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):682-6. PubMed ID: 580517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases].
    Hartemann P; Leclere J; Groussin M; Valdenaire JC; Maureira JJ; Belleville F; Nabet P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Jun; 6(4):537-46. PubMed ID: 915214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study.
    Friesen HG; Tolis G
    Clin Endocrinol (Oxf); 1977; 6 Suppl():91S-99S. PubMed ID: 617073
    [No Abstract]   [Full Text] [Related]  

  • 39. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
    Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of amantadine on prolactin levels and galactorrhea on neuroleptic-treated patients.
    Siever LJ
    J Clin Psychopharmacol; 1981 Jan; 1(1):2-7. PubMed ID: 6117579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.